Neurocrine Biosciences | NBIX - Ebitda





Ebitda Alterar Data
AbbVie USD 3.69B 1.68B 2026-03
Acadia Pharmaceuticals USD -1.62M 21.94M 2026-03
Agios Pharmaceuticals USD -108.66M 11.65M 2026-03
ALKERMES USD 139.22M 58.96M 2026-06
Alnylam Pharmaceuticals USD 245.34M 59.15M 2026-06
Amgen USD 3.86B 1.28B 2026-03
Biogen USD 649.7M 76.5M 2026-03
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Cytokinetics USD -169.32M 19.48M 2026-03
Exelixis USD 258.29M 15.43M 2026-03
Gilead Sciences USD 3.51B 489M 2026-03
Halozyme Therapeutics USD 219.57M 197.66M 2026-03
Incyte USD 778.57M 410.6M 2026-06
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
Nektar Therapeutics USD -38.9M 7.09M 2026-03
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Pfizer USD 6.01B 18M 2026-06
Prothena USD 25.98M 65.51M 2026-03
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Repligen USD 43.77M 3.76M 2026-06
Rigel Pharmaceuticals USD -4.17M 798K 2023-09
Sarepta Therapeutics USD 375.48M 627.68M 2026-03
Teva Pharmaceutical Industries USD 474M 581M 2026-06
Ultragenyx Pharmaceutical USD -155M 55.57M 2026-03
Vertex Pharmaceuticals USD 1.19B 195.3M 2026-03